| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | 7.71e-05 | 694 | 14 | 5 | GO:0003729 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.86e-03 | 134 | 14 | 2 | GO:0003697 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 2.31e-09 | 87 | 14 | 5 | GO:1902373 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 4.92e-09 | 101 | 14 | 5 | GO:1902369 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 9.49e-09 | 115 | 14 | 5 | GO:1903312 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 3.50e-08 | 917 | 14 | 8 | GO:0016071 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 1.75e-07 | 77 | 14 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 2.46e-07 | 443 | 14 | 6 | GO:1903311 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 3.00e-07 | 88 | 14 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | RNA splicing | 5.13e-07 | 502 | 14 | 6 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 8.85e-07 | 551 | 14 | 6 | GO:0006397 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 9.91e-07 | 292 | 14 | 5 | GO:0043488 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.29e-06 | 308 | 14 | 5 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 1.31e-06 | 309 | 14 | 5 | GO:0061013 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 3.30e-06 | 373 | 14 | 5 | GO:0006402 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 5.75e-06 | 418 | 14 | 5 | GO:0009895 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 6.75e-06 | 432 | 14 | 5 | GO:0006401 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 9.54e-06 | 464 | 14 | 5 | GO:0141188 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 9.65e-06 | 63 | 14 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.91e-05 | 79 | 14 | 3 | GO:0000380 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 2.20e-05 | 259 | 14 | 4 | GO:1903313 | |
| GeneOntologyBiologicalProcess | RNA processing | 2.31e-05 | 1500 | 14 | 7 | GO:0006396 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoplasmic translation | 5.78e-05 | 17 | 14 | 2 | GO:2000767 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 6.70e-05 | 696 | 14 | 5 | GO:0034655 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 7.78e-05 | 358 | 14 | 4 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 7.78e-05 | 358 | 14 | 4 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 8.13e-05 | 362 | 14 | 4 | GO:0000375 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 1.32e-04 | 151 | 14 | 3 | GO:0045727 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.04e-04 | 175 | 14 | 3 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.04e-04 | 175 | 14 | 3 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.14e-04 | 178 | 14 | 3 | GO:0051236 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 2.16e-04 | 1446 | 14 | 6 | GO:0010628 | |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic translation | 2.81e-04 | 37 | 14 | 2 | GO:2000765 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 3.34e-04 | 207 | 14 | 3 | GO:0043484 | |
| GeneOntologyBiologicalProcess | RNA localization | 3.84e-04 | 217 | 14 | 3 | GO:0006403 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 3.98e-04 | 44 | 14 | 2 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 4.94e-04 | 49 | 14 | 2 | GO:0050685 | |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | 5.15e-04 | 240 | 14 | 3 | GO:0060538 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 5.73e-04 | 249 | 14 | 3 | GO:0015931 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 7.09e-04 | 1153 | 14 | 5 | GO:0010608 | |
| GeneOntologyBiologicalProcess | regulation of alternative mRNA splicing, via spliceosome | 7.16e-04 | 59 | 14 | 2 | GO:0000381 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | 1.03e-03 | 1252 | 14 | 5 | GO:0009894 | |
| GeneOntologyBiologicalProcess | embryo development | 1.92e-03 | 1437 | 14 | 5 | GO:0009790 | |
| GeneOntologyBiologicalProcess | muscle structure development | 2.13e-03 | 858 | 14 | 4 | GO:0061061 | |
| GeneOntologyBiologicalProcess | muscle organ development | 2.87e-03 | 436 | 14 | 3 | GO:0007517 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | 3.29e-03 | 967 | 14 | 4 | GO:0071345 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 3.36e-03 | 129 | 14 | 2 | GO:0048024 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 3.52e-03 | 132 | 14 | 2 | GO:0000956 | |
| GeneOntologyBiologicalProcess | regulation of circadian rhythm | 3.68e-03 | 135 | 14 | 2 | GO:0042752 | |
| GeneOntologyBiologicalProcess | regulation of translation | 4.08e-03 | 494 | 14 | 3 | GO:0006417 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.23e-03 | 145 | 14 | 2 | GO:0051028 | |
| GeneOntologyBiologicalProcess | response to cytokine | 4.95e-03 | 1083 | 14 | 4 | GO:0034097 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.99e-03 | 158 | 14 | 2 | GO:0050684 | |
| GeneOntologyBiologicalProcess | response to peptide | 5.24e-03 | 1100 | 14 | 4 | GO:1901652 | |
| GeneOntologyBiologicalProcess | cytoplasmic translation | 5.89e-03 | 172 | 14 | 2 | GO:0002181 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 6.89e-03 | 596 | 14 | 3 | GO:0001701 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 8.35e-03 | 206 | 14 | 2 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 8.74e-03 | 211 | 14 | 2 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 8.74e-03 | 211 | 14 | 2 | GO:0061014 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway | 9.14e-03 | 216 | 14 | 2 | GO:2001242 | |
| GeneOntologyBiologicalProcess | pallium development | 9.64e-03 | 222 | 14 | 2 | GO:0021543 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | 9.72e-03 | 223 | 14 | 2 | GO:0007519 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 1.03e-02 | 230 | 14 | 2 | GO:0017148 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 1.19e-02 | 248 | 14 | 2 | GO:0007623 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 2.43e-05 | 269 | 14 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 3.12e-05 | 287 | 14 | 4 | GO:0035770 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 3.29e-05 | 96 | 14 | 3 | GO:0010494 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 8.68e-05 | 21 | 14 | 2 | GO:0035145 | |
| GeneOntologyCellularComponent | nuclear speck | 1.51e-04 | 431 | 14 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | mediator complex | 2.74e-04 | 37 | 14 | 2 | GO:0016592 | |
| GeneOntologyCellularComponent | spliceosomal complex | 3.59e-04 | 215 | 14 | 3 | GO:0005681 | |
| GeneOntologyCellularComponent | nuclear envelope | 4.12e-04 | 560 | 14 | 4 | GO:0005635 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 1.49e-03 | 1377 | 14 | 5 | GO:0140513 | |
| GeneOntologyCellularComponent | nuclear body | 2.45e-03 | 903 | 14 | 4 | GO:0016604 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 2.77e-03 | 934 | 14 | 4 | GO:0048471 | |
| GeneOntologyCellularComponent | organelle envelope | 1.27e-02 | 1435 | 14 | 4 | GO:0031967 | |
| Domain | THRAP3_BCLAF1 | 1.56e-06 | 3 | 14 | 2 | PF15440 | |
| Domain | THRAP3_BCLAF1 | 1.56e-06 | 3 | 14 | 2 | IPR029199 | |
| Domain | COLD_SHOCK | 7.81e-06 | 6 | 14 | 2 | PS00352 | |
| Domain | Cold-shock_CS | 7.81e-06 | 6 | 14 | 2 | IPR019844 | |
| Domain | CSD | 1.46e-05 | 8 | 14 | 2 | PF00313 | |
| Domain | CSP | 1.46e-05 | 8 | 14 | 2 | SM00357 | |
| Domain | CSP_DNA-bd | 1.46e-05 | 8 | 14 | 2 | IPR002059 | |
| Domain | Cold_shock_prot | 1.46e-05 | 8 | 14 | 2 | IPR011129 | |
| Domain | NA-bd_OB-fold | 2.97e-05 | 83 | 14 | 3 | IPR012340 | |
| Domain | RRM_1 | 4.53e-04 | 208 | 14 | 3 | PF00076 | |
| Domain | RRM | 5.12e-04 | 217 | 14 | 3 | SM00360 | |
| Domain | RRM_dom | 5.84e-04 | 227 | 14 | 3 | IPR000504 | |
| Domain | RRM | 6.07e-04 | 230 | 14 | 3 | PS50102 | |
| Domain | - | 7.21e-04 | 244 | 14 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 8.47e-04 | 258 | 14 | 3 | IPR012677 | |
| Pathway | WP_MRNA_PROCESSING | 1.47e-06 | 451 | 13 | 6 | MM15946 | |
| Pathway | WP_MRNA_PROCESSING | 4.09e-06 | 126 | 13 | 4 | M39406 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.20e-05 | 212 | 13 | 4 | M14033 | |
| Pathway | WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2 | 9.35e-05 | 16 | 13 | 2 | M39484 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 9.85e-05 | 283 | 13 | 4 | M13087 | |
| Pathway | KEGG_SPLICEOSOME | 1.91e-04 | 127 | 13 | 3 | M2044 | |
| Pathway | REACTOME_MRNA_SPLICING | 7.35e-04 | 201 | 13 | 3 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 8.65e-04 | 48 | 13 | 2 | MM15410 | |
| Pathway | REACTOME_MRNA_SPLICING_MINOR_PATHWAY | 9.38e-04 | 50 | 13 | 2 | M5583 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.85e-03 | 277 | 13 | 3 | MM15414 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 3.40e-03 | 724 | 13 | 4 | M16843 | |
| Pubmed | TRA2B YBX1 BCLAF1 PRRC2C THRAP3 SRSF8 YBX3 FXR1 CLASRP SRSF1 | 1.15e-14 | 713 | 14 | 10 | 29802200 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.38e-14 | 258 | 14 | 8 | 37794589 | |
| Pubmed | 2.53e-14 | 260 | 14 | 8 | 36199071 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 3.37e-12 | 807 | 14 | 9 | 22681889 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.96e-11 | 57 | 14 | 5 | 14559993 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 3.50e-11 | 169 | 14 | 6 | 23084401 | |
| Pubmed | 4.12e-11 | 655 | 14 | 8 | 35819319 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.42e-11 | 678 | 14 | 8 | 30209976 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 8.17e-11 | 714 | 14 | 8 | 28302793 | |
| Pubmed | 9.85e-11 | 731 | 14 | 8 | 29298432 | ||
| Pubmed | 1.06e-10 | 203 | 14 | 6 | 35012549 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 2.21e-10 | 462 | 14 | 7 | 31138677 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 3.14e-10 | 486 | 14 | 7 | 30940648 | |
| Pubmed | 3.21e-10 | 244 | 14 | 6 | 29884807 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 8.21e-10 | 558 | 14 | 7 | 27591049 | |
| Pubmed | 1.78e-09 | 138 | 14 | 5 | 30320910 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.89e-09 | 328 | 14 | 6 | 23398456 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 1.96e-09 | 330 | 14 | 6 | 33301849 | |
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 2.07e-09 | 333 | 14 | 6 | 32665550 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.91e-09 | 670 | 14 | 7 | 22990118 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.36e-09 | 361 | 14 | 6 | 26167880 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.75e-09 | 695 | 14 | 7 | 23602568 | |
| Pubmed | 5.39e-09 | 172 | 14 | 5 | 26336360 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 7.05e-09 | 1257 | 14 | 8 | 36526897 | |
| Pubmed | 8.40e-09 | 421 | 14 | 6 | 34650049 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 9.53e-09 | 430 | 14 | 6 | 38172120 | |
| Pubmed | 1.39e-08 | 1371 | 14 | 8 | 36244648 | ||
| Pubmed | 1.47e-08 | 847 | 14 | 7 | 35850772 | ||
| Pubmed | 1.66e-08 | 72 | 14 | 4 | 36123327 | ||
| Pubmed | 1.86e-08 | 74 | 14 | 4 | 33989516 | ||
| Pubmed | 1.98e-08 | 223 | 14 | 5 | 33731348 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 2.62e-08 | 922 | 14 | 7 | 27609421 | |
| Pubmed | 2.63e-08 | 236 | 14 | 5 | 36339263 | ||
| Pubmed | 3.17e-08 | 245 | 14 | 5 | 21182205 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.20e-08 | 949 | 14 | 7 | 36574265 | |
| Pubmed | 3.57e-08 | 251 | 14 | 5 | 31076518 | ||
| Pubmed | 4.15e-08 | 551 | 14 | 6 | 34728620 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 4.95e-08 | 268 | 14 | 5 | 33024031 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 7.21e-08 | 605 | 14 | 6 | 28977666 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 8.82e-08 | 626 | 14 | 6 | 33644029 | |
| Pubmed | 8.92e-08 | 109 | 14 | 4 | 29511296 | ||
| Pubmed | 1.20e-07 | 660 | 14 | 6 | 32780723 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.26e-07 | 665 | 14 | 6 | 30457570 | |
| Pubmed | 1.39e-07 | 330 | 14 | 5 | 32529326 | ||
| Pubmed | Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. | 1.50e-07 | 2 | 14 | 2 | 23778535 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 29112714 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 31944153 | ||
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 24817634 | ||
| Pubmed | Bcl-2-associated transcription factor 1 interacts with fragile X-related protein 1. | 1.50e-07 | 2 | 14 | 2 | 24389646 | |
| Pubmed | 1.50e-07 | 2 | 14 | 2 | 23748175 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.94e-07 | 353 | 14 | 5 | 27545878 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.17e-07 | 361 | 14 | 5 | 30344098 | |
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 3.13e-07 | 149 | 14 | 4 | 26370502 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 4.38e-07 | 162 | 14 | 4 | 31363146 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 4.49e-07 | 163 | 14 | 4 | 22113938 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 2977358 | ||
| Pubmed | The Y-box motif mediates redox-dependent transcriptional activation in mouse cells. | 4.51e-07 | 3 | 14 | 2 | 8530481 | |
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 16954378 | ||
| Pubmed | 4.51e-07 | 3 | 14 | 2 | 10713112 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 5.09e-07 | 1425 | 14 | 7 | 30948266 | |
| Pubmed | 5.56e-07 | 172 | 14 | 4 | 23184937 | ||
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 7.29e-07 | 45 | 14 | 3 | 25496916 | |
| Pubmed | 7.91e-07 | 469 | 14 | 5 | 27634302 | ||
| Pubmed | 7.93e-07 | 188 | 14 | 4 | 29721183 | ||
| Pubmed | 9.02e-07 | 4 | 14 | 2 | 7628487 | ||
| Pubmed | Cloning of a gene, YT521, for a novel RNA splicing-related protein induced by hypoxia/reoxygenation. | 9.02e-07 | 4 | 14 | 2 | 9473574 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 1.04e-06 | 954 | 14 | 6 | 36373674 | |
| Pubmed | Profiling of Parkin-binding partners using tandem affinity purification. | 1.08e-06 | 203 | 14 | 4 | 24244333 | |
| Pubmed | 1.10e-06 | 963 | 14 | 6 | 28671696 | ||
| Pubmed | 1.13e-06 | 52 | 14 | 3 | 26265008 | ||
| Pubmed | 1.16e-06 | 971 | 14 | 6 | 33306668 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 28785060 | ||
| Pubmed | 1.50e-06 | 5 | 14 | 2 | 16198352 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.57e-06 | 1024 | 14 | 6 | 24711643 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.70e-06 | 1038 | 14 | 6 | 26673895 | |
| Pubmed | 2.06e-06 | 239 | 14 | 4 | 26641092 | ||
| Pubmed | Rapid and systematic analysis of the RNA recognition specificities of RNA-binding proteins. | 2.25e-06 | 6 | 14 | 2 | 19561594 | |
| Pubmed | Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements. | 2.25e-06 | 6 | 14 | 2 | 17361132 | |
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 24100041 | ||
| Pubmed | 2.25e-06 | 6 | 14 | 2 | 25416801 | ||
| Pubmed | Functional association of human Ki-1/57 with pre-mRNA splicing events. | 2.25e-06 | 6 | 14 | 2 | 19523114 | |
| Pubmed | 2.28e-06 | 245 | 14 | 4 | 35652658 | ||
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 2.35e-06 | 247 | 14 | 4 | 39238192 | |
| Pubmed | 2.68e-06 | 69 | 14 | 3 | 35264565 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 2.71e-06 | 256 | 14 | 4 | 32698014 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 2.84e-06 | 259 | 14 | 4 | 30404004 | |
| Pubmed | 2.98e-06 | 615 | 14 | 5 | 31048545 | ||
| Pubmed | 3.18e-06 | 73 | 14 | 3 | 22094256 | ||
| Pubmed | 3.59e-06 | 76 | 14 | 3 | 36380368 | ||
| Pubmed | 3.65e-06 | 641 | 14 | 5 | 36057605 | ||
| Pubmed | 4.19e-06 | 80 | 14 | 3 | 25662211 | ||
| Pubmed | 4.20e-06 | 286 | 14 | 4 | 32041737 | ||
| Pubmed | SAF-B protein couples transcription and pre-mRNA splicing to SAR/MAR elements. | 4.21e-06 | 8 | 14 | 2 | 9671816 | |
| Pubmed | 4.21e-06 | 8 | 14 | 2 | 35194031 | ||
| Pubmed | 4.92e-06 | 1247 | 14 | 6 | 27684187 | ||
| Pubmed | 5.41e-06 | 9 | 14 | 2 | 14623875 | ||
| Pubmed | 5.41e-06 | 9 | 14 | 2 | 8871564 | ||
| Pubmed | 5.78e-06 | 89 | 14 | 3 | 36861887 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 6.00e-06 | 313 | 14 | 4 | 38270169 | |
| Pubmed | 6.05e-06 | 711 | 14 | 5 | 33022573 | ||
| Interaction | SRPK2 interactions | TRA2B YBX1 BCLAF1 PRRC2C THRAP3 SRSF8 YBX3 FXR1 CLASRP SRSF1 | 2.69e-12 | 717 | 14 | 10 | int:SRPK2 |
| Interaction | SRSF6 interactions | 6.27e-12 | 503 | 14 | 9 | int:SRSF6 | |
| Interaction | GSPT2 interactions | 5.64e-11 | 107 | 14 | 6 | int:GSPT2 | |
| Interaction | SUZ12 interactions | 5.71e-11 | 644 | 14 | 9 | int:SUZ12 | |
| Interaction | SNRNP70 interactions | TRA2B YBX1 BCLAF1 PRRC2C THRAP3 SRSF8 YBX3 FXR1 CLASRP SRSF1 | 6.17e-11 | 984 | 14 | 10 | int:SNRNP70 |
| Interaction | SRSF7 interactions | 9.85e-11 | 425 | 14 | 8 | int:SRSF7 | |
| Interaction | MAGOH interactions | 1.94e-10 | 264 | 14 | 7 | int:MAGOH | |
| Interaction | LUC7L2 interactions | 1.47e-09 | 353 | 14 | 7 | int:LUC7L2 | |
| Interaction | CLK2 interactions | 2.14e-09 | 195 | 14 | 6 | int:CLK2 | |
| Interaction | U2AF2 interactions | 2.87e-09 | 651 | 14 | 8 | int:U2AF2 | |
| Interaction | RC3H2 interactions | 3.48e-09 | 667 | 14 | 8 | int:RC3H2 | |
| Interaction | RC3H1 interactions | 3.91e-09 | 677 | 14 | 8 | int:RC3H1 | |
| Interaction | CLK1 interactions | 4.29e-09 | 219 | 14 | 6 | int:CLK1 | |
| Interaction | CLK3 interactions | 4.41e-09 | 220 | 14 | 6 | int:CLK3 | |
| Interaction | RNF113A interactions | 4.64e-09 | 692 | 14 | 8 | int:RNF113A | |
| Interaction | SRSF9 interactions | 4.92e-09 | 224 | 14 | 6 | int:SRSF9 | |
| Interaction | LARP4B interactions | 7.43e-09 | 240 | 14 | 6 | int:LARP4B | |
| Interaction | LUC7L interactions | 7.81e-09 | 242 | 14 | 6 | int:LUC7L | |
| Interaction | BTRC interactions | 1.13e-08 | 775 | 14 | 8 | int:BTRC | |
| Interaction | CLUH interactions | 1.28e-08 | 263 | 14 | 6 | int:CLUH | |
| Interaction | ZC3H18 interactions | 2.96e-08 | 877 | 14 | 8 | int:ZC3H18 | |
| Interaction | PABPC5 interactions | 3.08e-08 | 142 | 14 | 5 | int:PABPC5 | |
| Interaction | SRSF1 interactions | 4.03e-08 | 570 | 14 | 7 | int:SRSF1 | |
| Interaction | BARD1 interactions | 4.36e-08 | 323 | 14 | 6 | int:BARD1 | |
| Interaction | MYCN interactions | 4.51e-08 | 1373 | 14 | 9 | int:MYCN | |
| Interaction | NKAPD1 interactions | 5.78e-08 | 161 | 14 | 5 | int:NKAPD1 | |
| Interaction | PRC1 interactions | 6.65e-08 | 973 | 14 | 8 | int:PRC1 | |
| Interaction | EED interactions | 7.04e-08 | 1445 | 14 | 9 | int:EED | |
| Interaction | PAXIP1 interactions | 8.16e-08 | 359 | 14 | 6 | int:PAXIP1 | |
| Interaction | HNRNPC interactions | 8.36e-08 | 634 | 14 | 7 | int:HNRNPC | |
| Interaction | BRD7 interactions | 8.63e-08 | 637 | 14 | 7 | int:BRD7 | |
| Interaction | KIF23 interactions | 1.04e-07 | 1031 | 14 | 8 | int:KIF23 | |
| Interaction | SREK1 interactions | 1.10e-07 | 183 | 14 | 5 | int:SREK1 | |
| Interaction | RBM39 interactions | 1.13e-07 | 1042 | 14 | 8 | int:RBM39 | |
| Interaction | KIF20A interactions | 1.22e-07 | 1052 | 14 | 8 | int:KIF20A | |
| Interaction | ELAVL2 interactions | 1.25e-07 | 188 | 14 | 5 | int:ELAVL2 | |
| Interaction | PAN2 interactions | 1.48e-07 | 397 | 14 | 6 | int:PAN2 | |
| Interaction | SNIP1 interactions | 1.98e-07 | 417 | 14 | 6 | int:SNIP1 | |
| Interaction | THOC1 interactions | 2.17e-07 | 210 | 14 | 5 | int:THOC1 | |
| Interaction | NUDCD2 interactions | 2.18e-07 | 424 | 14 | 6 | int:NUDCD2 | |
| Interaction | CMTR1 interactions | 2.62e-07 | 218 | 14 | 5 | int:CMTR1 | |
| Interaction | SNRPC interactions | 2.71e-07 | 440 | 14 | 6 | int:SNRPC | |
| Interaction | FUS interactions | 2.80e-07 | 757 | 14 | 7 | int:FUS | |
| Interaction | THRAP3 interactions | 2.82e-07 | 443 | 14 | 6 | int:THRAP3 | |
| Interaction | SMG6 interactions | 2.86e-07 | 85 | 14 | 4 | int:SMG6 | |
| Interaction | ZBTB2 interactions | 3.09e-07 | 450 | 14 | 6 | int:ZBTB2 | |
| Interaction | NDN interactions | 3.22e-07 | 453 | 14 | 6 | int:NDN | |
| Interaction | TRIM31 interactions | 3.26e-07 | 454 | 14 | 6 | int:TRIM31 | |
| Interaction | ELK4 interactions | 3.93e-07 | 92 | 14 | 4 | int:ELK4 | |
| Interaction | SRPK1 interactions | 4.36e-07 | 477 | 14 | 6 | int:SRPK1 | |
| Interaction | DDRGK1 interactions | 4.57e-07 | 1249 | 14 | 8 | int:DDRGK1 | |
| Interaction | SNRPA interactions | 4.63e-07 | 482 | 14 | 6 | int:SNRPA | |
| Interaction | CHCHD2 interactions | 4.96e-07 | 248 | 14 | 5 | int:CHCHD2 | |
| Interaction | DANCR interactions | 6.87e-07 | 26 | 14 | 3 | int:DANCR | |
| Interaction | SF3B2 interactions | 6.98e-07 | 517 | 14 | 6 | int:SF3B2 | |
| Interaction | CYLD interactions | 7.06e-07 | 868 | 14 | 7 | int:CYLD | |
| Interaction | SRSF3 interactions | 7.38e-07 | 522 | 14 | 6 | int:SRSF3 | |
| Interaction | SF3A2 interactions | 7.97e-07 | 273 | 14 | 5 | int:SF3A2 | |
| Interaction | ECT2 interactions | 8.18e-07 | 887 | 14 | 7 | int:ECT2 | |
| Interaction | FMR1 interactions | 8.62e-07 | 536 | 14 | 6 | int:FMR1 | |
| Interaction | CAND1 interactions | 8.62e-07 | 894 | 14 | 7 | int:CAND1 | |
| Interaction | PRMT1 interactions | 1.12e-06 | 929 | 14 | 7 | int:PRMT1 | |
| Interaction | TNIP2 interactions | 1.32e-06 | 952 | 14 | 7 | int:TNIP2 | |
| Interaction | CIT interactions | 1.43e-06 | 1450 | 14 | 8 | int:CIT | |
| Interaction | ATXN2 interactions | 1.54e-06 | 312 | 14 | 5 | int:ATXN2 | |
| Interaction | SMC5 interactions | 1.83e-06 | 1000 | 14 | 7 | int:SMC5 | |
| Interaction | UFL1 interactions | 2.25e-06 | 1031 | 14 | 7 | int:UFL1 | |
| Interaction | HNRNPU interactions | 2.31e-06 | 1035 | 14 | 7 | int:HNRNPU | |
| Interaction | ATXN1 interactions | 2.37e-06 | 1039 | 14 | 7 | int:ATXN1 | |
| Interaction | APOBEC3D interactions | 2.64e-06 | 148 | 14 | 4 | int:APOBEC3D | |
| Interaction | BMI1 interactions | 2.87e-06 | 659 | 14 | 6 | int:BMI1 | |
| Interaction | MAGOHB interactions | 3.17e-06 | 155 | 14 | 4 | int:MAGOHB | |
| Interaction | NUPR1 interactions | 3.53e-06 | 683 | 14 | 6 | int:NUPR1 | |
| Interaction | AATF interactions | 3.84e-06 | 376 | 14 | 5 | int:AATF | |
| Interaction | WEE2-AS1 interactions | 3.88e-06 | 163 | 14 | 4 | int:WEE2-AS1 | |
| Interaction | PABPC1 interactions | 4.03e-06 | 699 | 14 | 6 | int:PABPC1 | |
| Interaction | PHAX interactions | 4.27e-06 | 167 | 14 | 4 | int:PHAX | |
| Interaction | SNRPF interactions | 4.31e-06 | 385 | 14 | 5 | int:SNRPF | |
| Interaction | DDX21 interactions | 4.71e-06 | 718 | 14 | 6 | int:DDX21 | |
| Interaction | RNF31 interactions | 5.38e-06 | 403 | 14 | 5 | int:RNF31 | |
| Interaction | PAIP2B interactions | 5.78e-06 | 52 | 14 | 3 | int:PAIP2B | |
| Interaction | ALYREF interactions | 6.28e-06 | 416 | 14 | 5 | int:ALYREF | |
| Interaction | CHD3 interactions | 6.39e-06 | 757 | 14 | 6 | int:CHD3 | |
| Interaction | TNIP1 interactions | 6.78e-06 | 1217 | 14 | 7 | int:TNIP1 | |
| Interaction | YWHAG interactions | 8.01e-06 | 1248 | 14 | 7 | int:YWHAG | |
| Interaction | BTF3 interactions | 8.71e-06 | 799 | 14 | 6 | int:BTF3 | |
| Interaction | PSAP interactions | 8.72e-06 | 200 | 14 | 4 | int:PSAP | |
| Interaction | NELFE interactions | 8.89e-06 | 201 | 14 | 4 | int:NELFE | |
| Interaction | DOT1L interactions | 9.22e-06 | 807 | 14 | 6 | int:DOT1L | |
| Interaction | SRSF11 interactions | 9.24e-06 | 203 | 14 | 4 | int:SRSF11 | |
| Interaction | TRIP4 interactions | 9.80e-06 | 206 | 14 | 4 | int:TRIP4 | |
| Interaction | RAD18 interactions | 9.92e-06 | 457 | 14 | 5 | int:RAD18 | |
| Interaction | CTCF interactions | 1.03e-05 | 461 | 14 | 5 | int:CTCF | |
| Interaction | GSK3A interactions | 1.07e-05 | 464 | 14 | 5 | int:GSK3A | |
| Interaction | NFX1 interactions | 1.09e-05 | 466 | 14 | 5 | int:NFX1 | |
| Interaction | IK interactions | 1.16e-05 | 215 | 14 | 4 | int:IK | |
| Interaction | SRSF5 interactions | 1.18e-05 | 474 | 14 | 5 | int:SRSF5 | |
| Interaction | BIRC3 interactions | 1.24e-05 | 1334 | 14 | 7 | int:BIRC3 | |
| Interaction | HNRNPK interactions | 1.27e-05 | 853 | 14 | 6 | int:HNRNPK | |
| Interaction | MIR138-1 interactions | 1.30e-05 | 68 | 14 | 3 | int:MIR138-1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 3.53e-03 | 294 | 14 | 2 | chr1p34 | |
| GeneFamily | Y box binding proteins | 5.14e-07 | 3 | 8 | 2 | 106 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 1.13e-05 | 12 | 8 | 2 | 737 | |
| GeneFamily | RNA binding motif containing | 3.69e-03 | 213 | 8 | 2 | 725 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 1.51e-05 | 1144 | 14 | 6 | MM3843 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 4.64e-05 | 1394 | 14 | 6 | M9585 | |
| Coexpression | SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM | 7.88e-05 | 161 | 14 | 3 | M5075 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 1.21e-04 | 186 | 14 | 3 | M4911 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 1.34e-04 | 523 | 14 | 4 | M12707 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN | 1.35e-04 | 193 | 14 | 3 | M7544 | |
| Coexpression | GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP | 1.41e-04 | 196 | 14 | 3 | M4928 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 1.45e-04 | 534 | 14 | 4 | MM1054 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN | 1.48e-04 | 199 | 14 | 3 | M8430 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 1.48e-04 | 199 | 14 | 3 | M6060 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 1.50e-04 | 200 | 14 | 3 | M5087 | |
| Coexpression | BIDUS_METASTASIS_UP | 2.01e-04 | 221 | 14 | 3 | M15866 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 2.44e-04 | 612 | 14 | 4 | M4772 | |
| Coexpression | LEE_RECENT_THYMIC_EMIGRANT | 2.53e-04 | 239 | 14 | 3 | M17496 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP | 2.62e-04 | 242 | 14 | 3 | M904 | |
| Coexpression | GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP | 4.45e-04 | 59 | 14 | 2 | M17730 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | 5.59e-04 | 761 | 14 | 4 | M11961 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | 5.89e-04 | 1407 | 14 | 5 | M14427 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 6.79e-06 | 806 | 14 | 6 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.61e-05 | 532 | 14 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.10e-04 | 403 | 14 | 4 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 1.16e-04 | 804 | 14 | 5 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 1.23e-04 | 815 | 14 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 1.26e-04 | 818 | 14 | 5 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 1.26e-04 | 819 | 14 | 5 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 9.20e-04 | 1257 | 14 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 1.12e-03 | 76 | 14 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.12e-03 | 323 | 14 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.19e-03 | 330 | 14 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 1.41e-03 | 790 | 14 | 4 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 1.45e-03 | 795 | 14 | 4 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 1.46e-03 | 797 | 14 | 4 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.47e-03 | 799 | 14 | 4 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 1.49e-03 | 801 | 14 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | 1.64e-03 | 822 | 14 | 4 | gudmap_developingGonad_e14.5_ testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.79e-03 | 843 | 14 | 4 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 1.80e-03 | 1459 | 14 | 5 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.03e-03 | 397 | 14 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.12e-03 | 105 | 14 | 2 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 2.16e-03 | 406 | 14 | 3 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.27e-03 | 413 | 14 | 3 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 191 | 14 | 4 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-07 | 191 | 14 | 4 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.66e-07 | 200 | 14 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 184 | 14 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.41e-05 | 185 | 14 | 3 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 191 | 14 | 3 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.65e-05 | 191 | 14 | 3 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 193 | 14 | 3 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 194 | 14 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 2.90e-05 | 197 | 14 | 3 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.95e-05 | 198 | 14 | 3 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 2.99e-05 | 199 | 14 | 3 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.99e-05 | 199 | 14 | 3 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.04e-05 | 200 | 14 | 3 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.04e-05 | 200 | 14 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.04e-05 | 200 | 14 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.53e-04 | 148 | 14 | 2 | 1d9fa6b2ee9feaed39c63d44e638b5c0942d947c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.00e-03 | 152 | 14 | 2 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-03 | 153 | 14 | 2 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-03 | 153 | 14 | 2 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD8-Trm/em_CD8|GI_large-bowel / Manually curated celltypes from each tissue | 1.07e-03 | 157 | 14 | 2 | d85304af4cd3b8aaedc5362a8223537e1b9dbec2 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-macrophage|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 57f02f2b9ce940a2962bb57cd8d02eb67b6f44a3 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | 155ac52a34e0d55545aab8a3e4162fc4c387e697 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 163 | 14 | 2 | c132fb5b56186a10d33ae5ce17b2a7e670d52f79 | |
| ToppCell | facs-Spleen-nan-24m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-03 | 165 | 14 | 2 | 966ed14d479e0f1a507f46d08408aa99bd7682ae | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.20e-03 | 166 | 14 | 2 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-03 | 166 | 14 | 2 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 167 | 14 | 2 | 73fdf4b81a45ec686d2929eaf641b434f70b7898 | |
| ToppCell | facs-Tongue-nan-24m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 167 | 14 | 2 | c4157fb31b44fe7c44be4215dda8ae2d37cf49a8 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-03 | 167 | 14 | 2 | 9a8e291c082d7c26bab21df77bd36ce927032a70 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_T-T_NK-Treg|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-03 | 168 | 14 | 2 | 99117480687e2b8e7521d3ae9e020791757ec48e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-03 | 170 | 14 | 2 | 74bb46826141bd1e80b4ce16e6bbfc770bd427d3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-03 | 170 | 14 | 2 | 6592ebe204b43b81c6b6da99e05da72c0983b3fa | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-03 | 173 | 14 | 2 | 46ed379571385684145b5cb6dd4ae340ac546e64 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-03 | 176 | 14 | 2 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-03 | 176 | 14 | 2 | 2a15437c5f5dbf6398d5ea70050632c24a7dc66c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-03 | 177 | 14 | 2 | 43dce527392f3b8364bb6a55268ce9d6518d3a29 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 178 | 14 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.37e-03 | 178 | 14 | 2 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-03 | 178 | 14 | 2 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-03 | 180 | 14 | 2 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-03 | 180 | 14 | 2 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.47e-03 | 184 | 14 | 2 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.47e-03 | 184 | 14 | 2 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-03 | 187 | 14 | 2 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 188 | 14 | 2 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 188 | 14 | 2 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.55e-03 | 189 | 14 | 2 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-03 | 190 | 14 | 2 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-03 | 190 | 14 | 2 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-03 | 190 | 14 | 2 | e792e42fc49472eaf974eb0905819eb51a1da8e5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-03 | 191 | 14 | 2 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-03 | 191 | 14 | 2 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-03 | 191 | 14 | 2 | 509d17d8ee0d028757ce0f2c9b97e5875f06f0ab | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-03 | 191 | 14 | 2 | e0072b392f8833fab5e1006148c46a17cce894bc | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 192 | 14 | 2 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | CF-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class | 1.59e-03 | 192 | 14 | 2 | da55719454b800b7e0cd6d5afd6332ecc5553218 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-03 | 192 | 14 | 2 | 550a6574a93acadb43c449094565c73ca51a0c5c | |
| ToppCell | 343B-Lymphocytic-B_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-03 | 193 | 14 | 2 | 361174a7b54c4d564b8f15000edc1b9d6a887739 | |
| ToppCell | 343B-Lymphocytic-B_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-03 | 193 | 14 | 2 | 8cbde0cc50643525b2744c9800e62fddc5eafcc5 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.61e-03 | 193 | 14 | 2 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-03 | 194 | 14 | 2 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 1.63e-03 | 194 | 14 | 2 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 195 | 14 | 2 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 195 | 14 | 2 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 1.64e-03 | 195 | 14 | 2 | 56f88ce95495260360bf08f9c76cc36e395dc6a9 | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.66e-03 | 196 | 14 | 2 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|World / Lineage, cell class and subclass | 1.66e-03 | 196 | 14 | 2 | 78b006922307c154622d71fcbc79ae5eed3f4b23 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.66e-03 | 196 | 14 | 2 | c87499aa570f8fab878c4c015e47c711a3a21e9c | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-03 | 196 | 14 | 2 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-03 | 196 | 14 | 2 | d4df86ce289835e76763213641989fde77935a16 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 1.66e-03 | 196 | 14 | 2 | 7c3a99f0893c43d8c7980b560503844573d3b03c | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 1.66e-03 | 196 | 14 | 2 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | primary_visual_cortex-Neuronal|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.66e-03 | 196 | 14 | 2 | 8efc2b3a95f57c31be203ac781b2098d4909297f | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.68e-03 | 197 | 14 | 2 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.68e-03 | 197 | 14 | 2 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.68e-03 | 197 | 14 | 2 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|lymphoid / Lineage, cell class and subclass | 1.68e-03 | 197 | 14 | 2 | a224c0a010489ad043bd2ad1385eef33c3b6b792 | |
| ToppCell | moderate-Epithelial-Basal|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.68e-03 | 197 | 14 | 2 | 6c81bcf6e16ffa7df40e2339feb3362ec3af8837 | |
| ToppCell | lymphoid-T_cell-unlabelled(multiplets)|T_cell / Lineage, cell class and subclass | 1.68e-03 | 197 | 14 | 2 | f215435aee15f0ed254104bfd55670144b6d2ac3 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-03 | 198 | 14 | 2 | 2a00648d3aa5843d9e924e054c5e973025f86e97 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.69e-03 | 198 | 14 | 2 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-03 | 198 | 14 | 2 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | Parenchymal-10x5prime-Hematologic-Erythrocyte-Erythrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-03 | 198 | 14 | 2 | 745e966fd52f06485061727cdbd9358b9df7d97d | |
| ToppCell | Parenchymal-10x5prime-Hematologic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-03 | 198 | 14 | 2 | 24b1138746dd69d1cda419f7070ef5a402d07563 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.69e-03 | 198 | 14 | 2 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 1.69e-03 | 198 | 14 | 2 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | mLN-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 1.69e-03 | 198 | 14 | 2 | 404ec46bd39b6f4d02a03ef38c30850bbbd8b608 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-03 | 198 | 14 | 2 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 1.69e-03 | 198 | 14 | 2 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 1.69e-03 | 198 | 14 | 2 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_3|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.69e-03 | 198 | 14 | 2 | 374d7a24e00cd3f435ca980123ab3c6a441c9ad5 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Basal|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.69e-03 | 198 | 14 | 2 | 5c52b69d65909b667ef0943e7e04572c9d5b1ba0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.69e-03 | 198 | 14 | 2 | aedd91e734bd919cf6b8c1586ad0cbd6e6d0f2ed | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-03 | 198 | 14 | 2 | 8be58e41ae7870d268e7ce5ab937769e2ecb60d9 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-03 | 198 | 14 | 2 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.69e-03 | 198 | 14 | 2 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| Computational | Neighborhood of SMC1L1 | 2.92e-05 | 62 | 11 | 3 | MORF_SMC1L1 | |
| Computational | Neighborhood of UBE2N | 1.05e-04 | 95 | 11 | 3 | MORF_UBE2N | |
| Computational | Neighborhood of APEX1 | 1.80e-04 | 114 | 11 | 3 | GCM_APEX1 | |
| Computational | Neighborhood of ACTG1 | 2.31e-04 | 124 | 11 | 3 | GCM_ACTG1 | |
| Computational | Genes in the cancer module 98. | 4.73e-04 | 393 | 11 | 4 | MODULE_98 | |
| Computational | Neighborhood of TDG | 5.56e-04 | 35 | 11 | 2 | GNF2_TDG | |
| Computational | Neighborhood of RAD21 | 6.22e-04 | 37 | 11 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of ANP32B | 6.22e-04 | 37 | 11 | 2 | GNF2_ANP32B | |
| Computational | Neighborhood of ACP1 | 1.10e-03 | 211 | 11 | 3 | MORF_ACP1 | |
| Computational | Neighborhood of DEK | 1.53e-03 | 58 | 11 | 2 | GNF2_DEK | |
| Computational | TFs and nuclear. | 1.53e-03 | 237 | 11 | 3 | MODULE_252 | |
| Computational | Genes in the cancer module 32. | 1.61e-03 | 241 | 11 | 3 | MODULE_32 | |
| Computational | Neighborhood of MCM5 | 1.69e-03 | 61 | 11 | 2 | GNF2_MCM5 | |
| Computational | Neighborhood of DDX5 | 1.91e-03 | 65 | 11 | 2 | GCM_DDX5 | |
| Computational | RNA splicing. | 1.91e-03 | 65 | 11 | 2 | MODULE_183 | |
| Computational | Neighborhood of DEK | 2.09e-03 | 264 | 11 | 3 | MORF_DEK | |
| Computational | Genes in the cancer module 198. | 3.09e-03 | 303 | 11 | 3 | MODULE_198 | |
| Computational | Neighborhood of APEX1 | 3.79e-03 | 92 | 11 | 2 | GNF2_APEX1 | |
| Computational | Neighborhood of RRM1 | 4.64e-03 | 102 | 11 | 2 | MORF_RRM1 | |
| Computational | Neighborhood of PTPN11 | 5.19e-03 | 108 | 11 | 2 | MORF_PTPN11 | |
| Computational | Neighborhood of HDAC1 | 5.37e-03 | 110 | 11 | 2 | GNF2_HDAC1 | |
| Computational | Neighborhood of DNMT1 | 6.16e-03 | 118 | 11 | 2 | MORF_DNMT1 | |
| Computational | Neighborhood of DAP3 | 6.26e-03 | 119 | 11 | 2 | GNF2_DAP3 | |
| Computational | Neighborhood of FBL | 9.30e-03 | 146 | 11 | 2 | GNF2_FBL | |
| Disease | Malignant neoplasm of breast | 1.30e-03 | 1074 | 14 | 4 | C0006142 | |
| Disease | COVID-19, mortality | 2.87e-03 | 170 | 14 | 2 | EFO_0004352, MONDO_0100096 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IYSGPRSHRRVPYRG | 111 | Q8NAT2 | |
| RSYSGRGRGRRGPNY | 381 | P51114 | |
| YRNNRGMRRPYGYRG | 61 | Q9NYF8 | |
| RYRGRGSEEYRAPRP | 361 | P05060 | |
| RGRGRGEYYSRGRSY | 1186 | Q9Y520 | |
| RGSRYSRSPYSRSPY | 151 | Q9BRL6 | |
| RRAPQYTFGYRRPYR | 136 | Q8IXM7 | |
| HRYSRSPARRGGYGP | 451 | Q8N2M8 | |
| HNRGYRRPYYFRGRN | 76 | Q9Y2W1 | |
| RRPYYFRGRNRGFYP | 81 | Q9Y2W1 | |
| RYRRGYYGRRRGPPR | 176 | P16989 | |
| YYGRRRGPPRNYAGE | 181 | P16989 | |
| RPYRRRRFPPYYMRR | 186 | P67809 | |
| RRFPPYYMRRPYGRR | 191 | P67809 | |
| YSPRRSRGSPRYSPR | 226 | Q07955 | |
| YSRYPPREYRASGSR | 96 | Q8NG27 | |
| RRRSPSPYYSRGGYR | 261 | P62995 | |
| SPYYSRGGYRSRSRS | 266 | P62995 | |
| AYPRRRRPGCYAYRQ | 11 | Q6NSJ0 |